Table 1: Patient characteristics at the time of transfer.
Patient Characteristics |
Subjects (n=39) |
Age, years |
29.0 ± 9.3 (18–57) |
Male, n (%) |
25/39 (64) |
Genotype |
|
Δ F508 homozygous, n (%) |
22 (56) |
Δ F508 heterozygous, n (%) |
14 (36) |
Other, n (%) |
3 (8) |
BMI, kg/m2
|
20.9 ± 3.2 (16.8–30.1) |
FEV1, L |
2.2 ± 1.1 (0.82–4.49) |
FEV1, % predicted |
57.7 ± 27.0 (24–120) |
FVC, L |
3.2 ± 1.3 (1.05–5.53) |
FVC, % predicted |
71.1 ± 25.6 (29–135) |
Pancreatic insufficiency, n (%) |
35/39 (90) |
Pseudomonas aeruginosa positive, n (%) |
21/39 (54) |
Cystic fibrosis-related diabetes, n (%) |
11/39 (28) |
Results are presented as mean ± standard deviation (range), or number of patients (%).
BMI, Body Mass Index; FEV1, Forced Expiratory Volume in 1 second; FVC, Forced Vital Capacity.